irs compliance glp-1 injectables wellness category receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These Wellness Program GLP-1 Treatment in

Eli Lilly responded to its rivals accusations with a statement saying that the trial which underpins its advertising, known as Surmount-5, is the only direct, head-to-head randomised clinical trial comparing tirzepatide and semaglutide in the context of weight management

Retatrutide delivers 24.2% weight loss vs Zepbound (20.9%) and Wegovy (14.9%)

These equivocal results might be explained by the sample size, the ethnic background, and the lifestyle of studied subjects

Vascular reactivity Studies have suggested that GLP-1 based therapies increase vascular nitric oxide production, thus improving systemic blood flow [46]

Aim for clear or pale-yellow urine as your hydration indicator